BioSpace News Archive

Pharm Country

PMV Pharmaceuticals to Participate in the Goldman Sachs Global 2023 Healthcare Conference

PMV Pharmaceuticals, Inc. announced that David H. Mack, Ph.D., President & Chief Executive Officer of PMV Pharmaceuticals, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference taking place in Dana Point, California June 12-15, 2023.

June 6, 2023
·
1 min read
Lone Star Bio

Lexicon Pharmaceuticals to Participate in the Jefferies 2023 Global Healthcare Conference

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies 2023 Global Healthcare Conference, taking place June 7-9, 2023.

June 6, 2023
·
3 min read
Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that management will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13, 2023 at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time).

June 6, 2023
·
1 min read
BioMidwest

NewAmsterdam Pharma Announces Commencement of Secondary Offering of Ordinary Shares

NewAmsterdam Pharma Company N.V. announced the commencement of an underwritten public offering of 10,579,210 of the Company’s ordinary shares, with a nominal value of €0.12 per share, by certain of the Company’s existing shareholders affiliated with Forbion Capital Partners.

June 6, 2023
·
6 min read
Biotech Bay

Vaxart, Inc. Announces Proposed Public Offering of Common Stock - June 06, 2023

Vaxart, Inc. announced that it has commenced an underwritten public offering of its common stock.

June 6, 2023
·
6 min read
BioMidwest

Cogent Biosciences Announces Proposed Public Offering of Common Stock - June 06, 2023

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced that it has commenced an underwritten public offering of $125 million of shares of its common stock.

June 6, 2023
·
5 min read
Biotech Bay

Outset Medical to Present at Goldman Sachs 44th Annual Global Healthcare Conference

Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced that members of management will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 8:00am PT / 11:00am ET.

June 6, 2023
·
1 min read
Biotech Bay

Vistagen to Present at Jefferies 2023 Global Healthcare Conference

Vistagen (Nasdaq: VTGN) today announced that its Chief Executive Officer, Shawn Singh, will present and host one-on-one meetings at the Jefferies Global Healthcare Conference taking place June 7 – 9, 2023 in New York City, NY.

June 6, 2023
·
2 min read
Telo Genomics Announces Private Placement Increased to $2,766,375 from Previously Announced Private Placement of $2,000,000

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “TELO”) is pleased to announce that it has increased the size of its previously announced non-brokered private placement (“Offering”) from up to $2 million in proceeds to $2,766,375 and 11,065,500 units (the “Units” or each a “Unit”).

June 6, 2023
·
4 min read
Biotech Beach

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - June 06, 2023

Puma Biotechnology, Inc., a biopharmaceutical company, announced that on June 2, 2023, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 22,500 shares of Puma common stock to three new non-executive employees.

June 6, 2023
·
2 min read